Interestingly, in pre-treatment melanoma, the abundance of proliferating antigen-experienced cytotoxic T cells (CD8+ CD45RO+ Ki67+) and the proximity of antigen-experienced cytotoxic T cells to melanoma cells correlated with positive responses to immune checkpoint inhibitors (ICIs) (46) (Figure 1C). Here, MKI67 is linked to melanoma.